Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

Tasci, Elif Senocak; Kutlu, Yasin; Olmez, Omer Fatih; Mutlu, Arda Ulas; Gundogdu, Yasemin; Seyyar, Mustafa; Sahin, Elif; Cabuk, Devrim; Majidova, Nargiz; Ugurlu, Irem; Demirci, Ayse; Aydin, Dincer; Cavdar, Eyup; Bayram, Selami; Yildirim, Nilgun; Karatas, Fatih; Eryilmaz, Melek Karakurt; Caglayan, Dilek; Menekse, Serkan; Kut, Engin; Arak, Haci; Keser, Murat; Sunar, Veli; Perkin, Perihan; Sakalar, Teoman; Oyan, Basak; Sonmez, Ozlem; Ozer, Leyla; Yildiz, Ibrahim

doi:10.1080/14656566.2024.2337261

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

Date

2024

Authors

dc.identifier.doi

10.1080/14656566.2024.2337261

dc.identifier.other

WOS:001196635300001

Publisher

TAYLOR \& FRANCIS LTD

DOI

10.1080/14656566.2024.2337261

Keywords

Capecitabine , breast cancer , residual tumor , triple negative , toxicity

URI

https://openaccess.acibadem.edu.tr/handle/11443/5855

Collections

WOS

Full item page

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By